Inhibition of oxidative drug metabolism by beta-adrenoceptor antagonists in related to their lipid solubility.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000818:Animals; D050356:Lipid Metabolism; D008297:Male; D004364:Pharmaceutical Preparations / Q000378:metabolism*; D051381:Rats; D011919:Rats, Inbred Strains; D012995:Solubility
D000319:Adrenergic beta-Antagonists; D004364:Pharmaceutical Preparations